Back to top
more

GSK PLC Sponsored ADR (GSK)

(Delayed Data from NYSE)

$52.07 USD

52.07
2,699,122

+0.29 (0.56%)

Updated Aug 25, 2026 04:00 PM ET

After-Market: $52.07 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (159 out of 246)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Here is how Amarin (AMRN) and GSK (GSK) have performed compared to their sector so far this year.

Zacks Equity Research

Are Construction Stocks Lagging EMCOR Group (EME) This Year?

by Zacks Equity Research

Here is how Emcor Group (EME) and Alfa Laval AB Unsponsored ADR (ALFVY) have performed compared to their sector so far this year.

Zacks Equity Research

Are Consumer Discretionary Stocks Lagging Accel Entertainment (ACEL) This Year?

by Zacks Equity Research

Here is how Accel Entertainment (ACEL) and Sendas Distribuidora S.A. Sponsored ADR (ASAIY) have performed compared to their sector so far this year.

Zacks Equity Research

Is EPR Properties (EPR) Stock Outpacing Its Finance Peers This Year?

by Zacks Equity Research

Here is how EPR Properties (EPR) and Aviva (AVVIY) have performed compared to their sector so far this year.

Zacks Equity Research

Is Adyen (ADYEY) Stock Outpacing Its Computer and Technology Peers This Year?

by Zacks Equity Research

Here is how Adyen N.V. Unsponsored ADR (ADYEY) and Intuit (INTU) have performed compared to their sector so far this year.

Zacks Equity Research

Is Central Japan Railway Co. (CJPRY) Stock Outpacing Its Transportation Peers This Year?

by Zacks Equity Research

Here is how Central Japan Railway Co. (CJPRY) and Copa Holdings (CPA) have performed compared to their sector so far this year.

Zacks Equity Research

Is FrancoNevada (FNV) Stock Outpacing Its Basic Materials Peers This Year?

by Zacks Equity Research

Here is how Franco-Nevada (FNV) and Fortuna Mining (FSM) have performed compared to their sector so far this year.

Zacks Equity Research

FDA Places Clinical Hold on Gilead's HIV Studies, Stock Down

by Zacks Equity Research

GILD slides 2.6% after FDA halts trials for HIV candidates, GS-1720 and GS-4182, over safety concerns in patients.

Zacks Equity Research

3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income

by Zacks Equity Research

The traditional retirement planning approaches no longer cover all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.

Zacks Equity Research

Here's Why GSK (GSK) is a Strong Value Stock

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.